Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
Capitalization 175B P/E ratio 2024 *
85.9x
P/E ratio 2025 * 74.6x
Enterprise value 116B EV / Sales 2024 *
21x
EV / Sales 2025 * 17.8x
Free-Float
99.29%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.31%
1 week+2.50%
Current month-0.25%
1 month+2.59%
3 months+15.41%
6 months+24.00%
Current year+45.66%
More quotes
1 week
477.08
Extreme 477.08
496.18
1 month
466.00
Extreme 466
496.18
Current year
320.26
Extreme 320.26
496.18
1 year
254.85
Extreme 254.85
496.18
3 years
180.07
Extreme 180.07
496.18
5 years
120.17
Extreme 120.1667
496.18
10 years
49.67
Extreme 49.6667
496.18
More quotes
Director TitleAgeSince
Chief Executive Officer 58 96-03-31
Director of Finance/CFO 52 13-03-31
President 56 96-02-29
Manager TitleAgeSince
Chief Executive Officer 58 96-03-31
Director/Board Member 66 07-10-18
President 56 96-02-29
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.31%+2.50%+66.27%+42.57%175B
+0.49%-1.01%+19.13%+9.58%235B
+0.65%+1.08%+8.14%-14.81%199B
+0.24%+1.04%+57.86%+85.99%123B
+0.54%-1.38%+9.15%-14.52%61.32B
+1.23%+5.55%-5.25%-42.53%41.78B
-0.31%+1.79%+30.42% - 39.57B
-0.20%-4.31%-16.42%-29.48%39.5B
+0.73%+0.16%+19.33%-20.18%39.74B
+1.14%+0.89%+73.17%-12.02%36.99B
Average +0.48%+0.89%+26.18%+0.51% 99.05B
Weighted average by Cap. +0.47%+1.05%+29.45%+12.86%
See all sector performances
2024 *2025 *
Net sales 8.1B 9.4B
Net income 2.06B 2.37B
Net Debt -4.85B -7.04B
More financial data * Estimated data
Logo Intuitive Surgical, Inc.
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Employees
13,676
More about the company
Date Price Change Volume
24-09-17 487.54 $ -0.78% 351,243
24-09-16 491.39 $ +0.31% 921,409
24-09-13 489.86 $ -0.84% 1,238,094
24-09-12 494.01 $ +0.63% 1,128,767
24-09-11 490.93 $ +1.38% 1,239,274

Delayed Quote Nasdaq, September 16, 2024 at 04:00 pm EDT

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
491.39USD
Average target price
483.95USD
Spread / Average Target
-1.51%
Consensus
-40% Exceptional Extension: Our subscriptions help you unlock hidden opportunities. Exceptional extension!
BENEFIT NOW